COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 35 filers reported holding COMPASS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $124,679 | -67.0% | 63,289 | -46.8% | 0.00% | – |
| Q2 2023 | $378,089 | -27.8% | 118,896 | -25.7% | 0.00% | – |
| Q1 2023 | $523,409 | +61.3% | 160,064 | +148.2% | 0.00% | – |
| Q4 2022 | $324,425 | +1522.1% | 64,498 | +627.0% | 0.00% | – |
| Q3 2022 | $20,000 | +900.0% | 8,872 | +1347.3% | 0.00% | – |
| Q2 2022 | $2,000 | -94.6% | 613 | -97.7% | 0.00% | – |
| Q1 2022 | $37,000 | -33.9% | 26,977 | +54.4% | 0.00% | – |
| Q4 2021 | $56,000 | – | 17,473 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,500,000 | $11,165,000 | 7.28% |
| Foresite Capital Management V, LLC | 4,400,000 | $13,948,000 | 3.43% |
| CHI Advisors LLC | 3,023,692 | $9,585,000 | 3.18% |
| Foresite Capital Opportunity Management V, LLC | 1,100,000 | $3,487,000 | 2.34% |
| Monashee Investment Management LLC | 2,000,000 | $6,340,000 | 1.57% |
| Orbimed Advisors | 21,642,975 | $68,608,000 | 0.88% |
| Rock Springs Capital Management LP | 5,328,088 | $16,890,000 | 0.39% |
| Vivo Capital, LLC | 2,000,000 | $6,340,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 700,000 | $2,219,000 | 0.24% |
| DAFNA Capital Management LLC | 196,091 | $622,000 | 0.16% |